Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Body Fatness, Adipose Tissue Compartments, and Biomarkers of Inflammation and Angiogenesis in Colorectal Cancer: The ColoCare Study.

Himbert C, Ose J, Nattenmüller J, Warby CA, Holowatyj AN, Böhm J, Lin T, Haffa M, Gigic B, Hardikar S, Scherer D, Zielske L, Schrotz-King P, Kölsch T, Siegel EM, Shibata D, Ulrich A, Schneider M, Hursting SD, Kauczor HU, Ulrich CM.

Cancer Epidemiol Biomarkers Prev. 2019 Jan;28(1):76-82. doi: 10.1158/1055-9965.EPI-18-0654. Epub 2018 Oct 17.

PMID:
30333223
2.

Inflammation- and angiogenesis-related biomarkers are correlated with cancer-related fatigue in colorectal cancer patients: Results from the ColoCare Study.

Himbert C, Ose J, Lin T, Warby CA, Gigic B, Steindorf K, Schrotz-King P, Abbenhardt-Martin C, Zielske L, Boehm J, Ulrich CM.

Eur J Cancer Care (Engl). 2019 Apr 24:e13055. doi: 10.1111/ecc.13055. [Epub ahead of print]

PMID:
31016796
3.

Correlation between Non-Alcoholic Fatty Liver Disease and Visceral Adipose Tissue in Non-Obese Chinese Adults: A CT Evaluation.

Yu AH, Duan-Mu YY, Zhang Y, Wang L, Guo Z, Yu YQ, Wang YS, Cheng XG.

Korean J Radiol. 2018 Sep-Oct;19(5):923-929. doi: 10.3348/kjr.2018.19.5.923. Epub 2018 Aug 6.

4.

Validating quantitative obesity measurements in colorectal cancer patients.

Balentine CJ, Marshall C, Robinson C, Wilks J, Anaya D, Albo D, Berger DH.

J Surg Res. 2010 Nov;164(1):18-22. doi: 10.1016/j.jss.2010.05.048. Epub 2010 Jun 13.

PMID:
20828744
5.

CT-based compartmental quantification of adipose tissue versus body metrics in colorectal cancer patients.

Nattenmueller J, Hoegenauer H, Boehm J, Scherer D, Paskow M, Gigic B, Schrotz-King P, Grenacher L, Ulrich C, Kauczor HU.

Eur Radiol. 2016 Nov;26(11):4131-4140. Epub 2016 Feb 6.

6.

Association between visceral and subcutaneous adiposity and clinicopathological outcomes in non-metastatic clear cell renal cell carcinoma.

Mano R, Hakimi AA, Zabor EC, Bury MA, Donati OF, Karlo CA, Bazzi WM, Furberg H, Russo P.

Can Urol Assoc J. 2014 Sep;8(9-10):E675-80. doi: 10.5489/cuaj.1979.

7.

Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancer.

Guiu B, Petit JM, Bonnetain F, Ladoire S, Guiu S, Cercueil JP, Krausé D, Hillon P, Borg C, Chauffert B, Ghiringhelli F.

Gut. 2010 Mar;59(3):341-7. doi: 10.1136/gut.2009.188946. Epub 2009 Oct 15.

PMID:
19837679
8.

Abdominal fat distribution measured using computed tomography is associated with an increased risk of colorectal adenoma in men.

Seo IK, Kim BJ, Kim B, Choi CH, Kim JW, Kim JG, Chang SK, Kang H.

Medicine (Baltimore). 2017 Sep;96(37):e8051. doi: 10.1097/MD.0000000000008051.

9.

Semiautomated Measure of Abdominal Adiposity Using Computed Tomography Scan Analysis.

Srikumar T, Siegel EM, Gu Y, Balagurunathan Y, Garcia AL, Chen YA, Zhou JM, Zhao X, Gillies R, Clark W, Gamenthaler A, Choi J, Shibata D.

J Surg Res. 2019 May;237:12-21. doi: 10.1016/j.jss.2018.11.027. Epub 2019 Jan 14.

PMID:
30694786
10.
11.

The Impact of Abdominal Fat Levels on All-Cause Mortality Risk in Patients Undergoing Hemodialysis.

Yajima T, Yajima K, Takahashi H, Yasuda K.

Nutrients. 2018 Apr 12;10(4). pii: E480. doi: 10.3390/nu10040480.

12.

Visceral obesity may affect oncologic outcome in patients with colorectal cancer.

Moon HG, Ju YT, Jeong CY, Jung EJ, Lee YJ, Hong SC, Ha WS, Park ST, Choi SK.

Ann Surg Oncol. 2008 Jul;15(7):1918-22. doi: 10.1245/s10434-008-9891-4. Epub 2008 Apr 5.

PMID:
18392660
13.

Abdominal Visceral to Subcutaneous Adipose Tissue Ratio Is Associated with Increased Risk of Erosive Esophagitis.

Ze EY, Kim BJ, Kang H, Kim JG.

Dig Dis Sci. 2017 May;62(5):1265-1271. doi: 10.1007/s10620-017-4467-4. Epub 2017 Mar 9.

14.

[Association of abdominal fat distribution by computed tomography with body mass index and metabolic syndrome in Chinese elders].

Wang C, Wang X, Tian H, Fang F, Han X.

Zhonghua Yi Xue Za Zhi. 2014 Apr 1;94(12):908-12. Chinese.

PMID:
24854910
15.

Impact of visceral fat on gene expression profile in peripheral blood cells in obese Japanese subjects.

Obata Y, Maeda N, Yamada Y, Yamamoto K, Nakamura S, Yamaoka M, Tanaka Y, Masuda S, Nagao H, Fukuda S, Fujishima Y, Kita S, Nishizawa H, Funahashi T, Matsubara KI, Matsuzawa Y, Shimomura I.

Cardiovasc Diabetol. 2016 Nov 29;15(1):159.

16.

Clinical Impact of Abdominal Fat Distribution on Prognosis After Esophagectomy for Esophageal Squamous Cell Carcinoma.

Okamura A, Watanabe M, Mine S, Nishida K, Imamura Y, Kurogochi T, Kitagawa Y, Sano T.

Ann Surg Oncol. 2016 Apr;23(4):1387-94. doi: 10.1245/s10434-015-5018-x. Epub 2015 Dec 14.

PMID:
26668084
17.

CT-based assessment of visceral adiposity and outcomes for esophageal adenocarcinoma.

Saeed N, Shridhar R, Almhanna K, Hoffe S, Chuong M, Meredith K.

J Gastrointest Oncol. 2017 Oct;8(5):833-841. doi: 10.21037/jgo.2017.07.03.

18.

Subcutaneous and total fat at L4-L5 and subcutaneous, visceral and total fat at L3-L4 are important contributors of fasting and postprandial adiponectin levels.

Katergari SA, Passadakis P, Milousis A, Passadaki T, Asimakopoulos B, Mantatzis M, Prassopoulos P, Tripsianis G, Nikolettos N, Papachristou DN.

Endocr Res. 2015;40(3):127-32. doi: 10.3109/07435800.2014.920349. Epub 2015 Mar 16.

PMID:
25774471
19.

Increased subcutaneous fat accumulation has a protective role against subclinical atherosclerosis in asymptomatic subjects undergoing general health screening.

Narumi H, Yoshida K, Hashimoto N, Umehara I, Funabashi N, Yoshida S, Komuro I.

Int J Cardiol. 2009 Jun 26;135(2):150-5. doi: 10.1016/j.ijcard.2008.03.044. Epub 2008 Jul 1.

PMID:
18593641
20.

Abdominal subcutaneous adipose tissue: a favorable adipose depot for diabetes?

Chen P, Hou X, Hu G, Wei L, Jiao L, Wang H, Chen S, Wu J, Bao Y, Jia W.

Cardiovasc Diabetol. 2018 Jun 26;17(1):93. doi: 10.1186/s12933-018-0734-8.

Supplemental Content

Support Center